These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 9732392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP, Dunlow LD, Patrick GS, Razdan RK.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [Abstract] [Full Text] [Related]

  • 4. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU, Lamb RJ, Lin S, Makriyannis A.
    Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
    [Abstract] [Full Text] [Related]

  • 5. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    Anikwue R, Huffman JW, Martin ZL, Welch SP.
    J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
    [Abstract] [Full Text] [Related]

  • 6. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ, Eads M, Embrey JP, Welch SP.
    Brain Res; 2000 Feb 28; 857(1-2):337-42. PubMed ID: 10700588
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM, Wakley AA, Tsutsui KT, Laggart JD.
    J Pharmacol Exp Ther; 2012 Mar 28; 340(3):787-800. PubMed ID: 22182934
    [Abstract] [Full Text] [Related]

  • 9. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA, Janoyan JJ, Crim J, Ramirez J.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):187-96. PubMed ID: 17362921
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK.
    J Pharmacol Exp Ther; 2002 Oct 01; 303(1):314-22. PubMed ID: 12235266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL, Cichewicz DL, Welch SP.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):60-8. PubMed ID: 16919265
    [Abstract] [Full Text] [Related]

  • 13. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE, Kendall DA, Randall MD.
    Eur J Pharmacol; 2005 Jan 10; 507(1-3):211-21. PubMed ID: 15659311
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14136-41. PubMed ID: 10570211
    [Abstract] [Full Text] [Related]

  • 15. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
    Lake KD, Compton DR, Varga K, Martin BR, Kunos G.
    J Pharmacol Exp Ther; 1997 Jun 23; 281(3):1030-7. PubMed ID: 9190833
    [Abstract] [Full Text] [Related]

  • 16. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP, Thomas C, Patrick GS.
    J Pharmacol Exp Ther; 1995 Jan 23; 272(1):310-21. PubMed ID: 7815346
    [Abstract] [Full Text] [Related]

  • 17. Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.
    Welch SP.
    Drug Alcohol Depend; 1997 Apr 14; 45(1-2):39-45. PubMed ID: 9179505
    [Abstract] [Full Text] [Related]

  • 18. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
    Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, Deng H, Makriyannis A, Dey SK.
    Biol Reprod; 1998 Jun 14; 58(6):1490-5. PubMed ID: 9623610
    [Abstract] [Full Text] [Related]

  • 19. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
    Raffa RB, Stone DJ, Hipp SJ.
    Neurosci Lett; 1999 Mar 19; 263(1):29-32. PubMed ID: 10218903
    [Abstract] [Full Text] [Related]

  • 20. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.
    Compton DR, Aceto MD, Lowe J, Martin BR.
    J Pharmacol Exp Ther; 1996 May 19; 277(2):586-94. PubMed ID: 8627535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.